A man receives a shot from a health worker, both wear masks and protective gear.


PRI audio player

A month into its COVID-19 vaccine rollout, Zimbabwe has struggled to surpass the 75,000 mark as some front-line health workers are skeptical about the Chinese-made Sinopharm efficacy rate. 

Player utilities

Read the full story at TheWorld.org.

A citizen gets a Sinopharm vaccine against the coronavirus at the Zimbabwean main vaccination center, Wilkins Hospital, March 31, 2021, in Harare. 


Columbus S. Mavhunga/The World 

Related Stories


We use cookies to understand how you use our site and to improve your experience. To learn more, review our Cookie Policy. By continuing to use our site, you accept our use of cookies and Privacy Policy.

Ok, I understand. Close

The story you just read is freely available and accessible to everyone because readers like you support The World financially. 

Thank you all for helping us reach our goal of 1,000 donors. We couldn’t have done it without your support. Your donation directly supported the critical reporting you rely on, the consistent reporting you believe in, and the deep reporting you want to ensure survives. 

DONATE TODAY > No thanks